RecruitingNCT02038660
Drug-Eluting Balloon Registry in Routine Clinical Practice
Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
Sponsor
Seung-Jung Park
Enrollment
1,500 participants
Start Date
Jan 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.
Eligibility
Min Age: 20 Years
Inclusion Criteria4
- After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
- Age 20 and more
- Treated with Balloon angioplasty
- Signed informed consent and agreed to follow protocol
Exclusion Criteria3
- Allergy to paclitaxel, antiplatelet
- History of side effect to heparin, aspirin, thienopyridines
- History of bleeding tendency, coagulation disorder, blood transfusion reaction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEBalloon angioplasty
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02038660
Related Trials
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120146 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069012 locations
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
NCT062590194 locations
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT0677963017 locations
Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure
NCT057703491 location